$2.8B emerging markets impact VC investing in healthcare and financial services in Africa and Asia. Recent 2026 Asia healthcare investments active (Pharmacity Vietnam, Global Care Medical Center). Offices in London, Singapore, Nairobi, Mumbai, Sydney.
LeapFrog's $2.8B mandate is to invest in healthcare companies that reach underserved populations in Asia and Africa — and MOVO-X already operates in both. Our Malaysia and Singapore deployments serve the ASEAN market LeapFrog just re-entered with their 2026 Vietnam healthcare investment; our Morocco deployment (84 cities) is the Africa proof-point that makes MOVO-X stand out. We are not promising future expansion — we are already there, with compliant infrastructure, live deployments, and a FHIR R4 data layer that LeapFrog's impact thesis demands.
Malaysia's largest private hospital group. Bursa-listed. JCorp majority. 30+ hospitals across 13 Malaysian states. Advanced discussions underway — significant potential for enterprise-wide AI triage, queue management, and kiosk check-in deployment.
Multi-tenant SaaS active across Quebec and Ontario clinic networks. PIPEDA + Law 25 compliant. Interac and Stripe payments. Architecture validated across clinic groups.
Full PDPA (SG), HBRA, and NEHR integration architecture complete. PayNow + NETS + Stripe. English and Mandarin. Strong pipeline potential with Singapore hospital groups.
We'd love to walk you through our product, architecture, and pipeline. If healthcare AI in ASEAN fits your mandate, we should have a conversation.